MILFAM
VC Fund
MILFAM is a family investment office.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries MILFAM invests in
Stages MILFAM invests in
Countries MILFAM invests in
Investment Focus
Industry
- Energy 2 (67%)
- Nuclear 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
Stage
- Venture - Series Unknown 2 (67%)
- Seed 1 (33%)
Country
- Canada 1 (33%)
- Israel 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
General Fusion
|
General Fusion pursues a commercially oriented path toward fusion energy by developing a magnetized target fusion (MTF) technology. The company applies advances in plasma physics, modern electronics, materials, and compression mechanisms to generate fusion-relevant conditions. It operates a demonstration system, Lawson Machine 26 (LM26), thatinjects magnetized plasma into a liquid metal liner and compresses it using coordinated mechanical pistons to reach high temperatures and pressures. The technology serves as a practical stepping stone toward building a fusion demonstration facility and ultimately delivering fusion-derived electricity to the grid. The approach focuses on closing the gap between demonstration milestones and a deployable power-plant system. | $21.6M / Venture - Series Unknown / Aug 21, 2025 | |
Type One Energy
|
Type One Energy is a fusion power system developer whose goal is to provide clean fusion power to cities. Through innovations in high-temp superconducting magnets and additive manufacturing, the company's system connects the compact, cost-effective stellarator fusion power plant to the grid, allowing people to access power when it is needed. | $29M / Seed / Mar 28, 2023 | |
Nucleix
|
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called LungEpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel. | $55M / Venture - Series Unknown / Apr 07, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does MILFAM invest in?
MILFAM invests primarily in Energy, Nuclear and Health Care startups, most often at Venture - Series Unknown and Seed stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did MILFAM last invest?
The most recent investment recorded for MILFAM closed in Aug 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
